Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0PJ3R
|
||||
| Former ID |
DNC012690
|
||||
| Drug Name |
(Z)-2-Methyl-1-oxazol-2-yl-octadec-9-en-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [526085] | ||
| Formula |
C22H37NO2
|
||||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCC(C)C(=O)C1=NC=CO1
|
||||
| InChI |
1S/C22H37NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(2)21(24)22-23-18-19-25-22/h10-11,18-20H,3-9,12-17H2,1-2H3/b11-10-
|
||||
| InChIKey |
VNDQKKVLWCFNIJ-KHPPLWFESA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [526085] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.